Migraine Management in Japan: Current Approaches and Science Narrative Including an Evidence-based Review
Year: 2024
Type: article
Abstract: Migraine is a prevalent and highly disabling neurological disorder. Recent progress in neuroscientific research has contributed to the development of new therapies for migraine, including triptans, ditans, calcitonin gene-related peptide (CGRP) antagonists, and CGRP-related monoclonal antibodies. Noninvasive neuromodulation devices have also been developed. We herein review the recent advances in research and the current standard of management for migraine patients.
Source: Internal Medicine
Authors: Takao Takeshima, Shoji Kikui, Daisuke Danno
Institution: Tominaga hospital
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4405536668